The year started strong for Jazz Pharmaceuticals (JAZZ) with a Q4 2024 revenue beat and the company guiding 2025 revenues just slightly below the analyst consensus. However, the stock is down 22% ...
It’s one step forward, two steps back with the New Jersey Devils this season. Certainly, they’re far removed from the team that won eight straight games at the beginning of the season. They’re not ...
ARLINGTON - The Rangers offense seemed to take a step forward on Tuesday. It took two steps back Wednesday. Cliché? Sure. But you try writing the 15th episode of How the Offense Didn't Score in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results